Suppr超能文献

血清维生素 D 浓度低与肥胖而非瘦型非酒精性脂肪性肝病相关:一项横断面研究。

Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study.

机构信息

Department of Gastroenterology, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, China.

Department of Laboratory Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

出版信息

Nutr J. 2021 Apr 1;20(1):30. doi: 10.1186/s12937-021-00690-9.

Abstract

BACKGROUND

A low serum vitamin D concentration has been reported to be associated with an increased risk of non-alcoholic fatty liver disease (NAFLD); however, whether lean or obese individuals show a similar association between vitamin D and NAFLD remains speculative. This study aimed to explore the relationship between serum vitamin D concentration and NAFLD in lean and obese Chinese adults.

METHODS

This cross-sectional study included 2538 participants (1360 men and 1178 women) who underwent health checkups at the First Affiliated Hospital, Zhejiang University School of Medicine in 2019. NAFLD was diagnosed by liver ultrasound excluding other causes. The association of serum vitamin D concentration with NAFLD was analyzed in lean and obese participants.

RESULTS

The overall prevalence of NAFLD was 33.61% (13.10% in lean and 53.32% in obese) in this study population. The serum vitamin D levels of obese NAFLD patients were lower than those of obese NAFLD-free controls. However, the serum vitamin D levels of lean NAFLD patients were comparable to those of lean NAFLD-free controls. Serum vitamin D level was negatively correlated with the prevalence of NAFLD in obese but not lean participants. Serum vitamin D level was independently associated with the risk of NAFLD in obese participants, with an adjusted odds ratio (95% CI) of 0.987 (0.981-0.993). However, serum vitamin D level was not related to the risk of NAFLD in lean participants.

CONCLUSIONS

A low serum vitamin D level is associated with NAFLD in obese but not lean participants.

摘要

背景

有报道称血清维生素 D 浓度低与非酒精性脂肪性肝病(NAFLD)风险增加有关;然而,瘦或肥胖个体的维生素 D 与 NAFLD 之间是否存在类似的关联仍存在推测。本研究旨在探讨血清维生素 D 浓度与中国瘦和肥胖成年人 NAFLD 之间的关系。

方法

本横断面研究纳入了 2019 年在浙江大学医学院附属第一医院进行健康检查的 2538 名参与者(男 1360 名,女 1178 名)。NAFLD 通过排除其他原因的肝脏超声诊断。分析了瘦和肥胖参与者血清维生素 D 浓度与 NAFLD 的关系。

结果

在该研究人群中,NAFLD 的总体患病率为 33.61%(瘦组为 13.10%,肥胖组为 53.32%)。肥胖 NAFLD 患者的血清维生素 D 水平低于肥胖非 NAFLD 对照组。然而,瘦 NAFLD 患者的血清维生素 D 水平与瘦非 NAFLD 对照组相当。血清维生素 D 水平与肥胖参与者的 NAFLD 患病率呈负相关,但与瘦参与者的 NAFLD 患病率无关。血清维生素 D 水平与肥胖参与者的 NAFLD 风险独立相关,调整后的优势比(95%CI)为 0.987(0.981-0.993)。然而,血清维生素 D 水平与瘦参与者的 NAFLD 风险无关。

结论

血清维生素 D 水平低与肥胖参与者的 NAFLD 相关,但与瘦参与者的 NAFLD 无关。

相似文献

2
Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
Indian J Gastroenterol. 2020 Feb;39(1):75-83. doi: 10.1007/s12664-020-01020-3. Epub 2020 Apr 20.
3
Positive Association Between the Chinese Visceral Adiposity Index and Nonalcoholic Fatty Liver Disease in Lean Adults.
Dig Dis Sci. 2023 Feb;68(2):656-664. doi: 10.1007/s10620-022-07787-z. Epub 2022 Dec 13.
4
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
5
Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study.
J Nutr Sci Vitaminol (Tokyo). 2019;65(4):303-308. doi: 10.3177/jnsv.65.303.

引用本文的文献

2
Current strategies for nonalcoholic fatty liver disease treatment (Review).
Int J Mol Med. 2024 Oct;54(4). doi: 10.3892/ijmm.2024.5412. Epub 2024 Aug 12.
4
5
Vitamin D improves hepatic steatosis in NAFLD regulation of fatty acid uptake and β-oxidation.
Front Endocrinol (Lausanne). 2023 Mar 22;14:1138078. doi: 10.3389/fendo.2023.1138078. eCollection 2023.
6
Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease.
Can J Gastroenterol Hepatol. 2022 Jun 28;2022:7175108. doi: 10.1155/2022/7175108. eCollection 2022.

本文引用的文献

3
Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016.
J Intern Med. 2020 Jul;288(1):139-151. doi: 10.1111/joim.13069. Epub 2020 Apr 22.
4
Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12.
6
Association between Vitamin D Status and Non-Alcoholic Fatty Liver Disease: A Population-Based Study.
J Nutr Sci Vitaminol (Tokyo). 2019;65(4):303-308. doi: 10.3177/jnsv.65.303.
8
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29.
9
Lean non-alcoholic fatty liver disease.
Clin Nutr. 2019 Jun;38(3):975-981. doi: 10.1016/j.clnu.2018.08.008. Epub 2018 Aug 17.
10
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
J Dig Dis. 2019 Apr;20(4):163-173. doi: 10.1111/1751-2980.12685. Epub 2018 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验